APA

Beebe J. S., Jani J. P., Knauth E., Goodwin P., Higdon C., Rossi A. M., Emerson E., Finkelstein M., Floyd E., Harriman S., Atherton J., Hillerman S., Soderstrom C., Kou K., Gant T., Noe M. C., Foster B., Rastinejad F., Marx M. A., Schaeffer T., Whalen P. M. & Roberts W. G. (20040116). Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy. : Cancer research.

Chicago

Beebe Jean S, Jani Jitesh P, Knauth Elisabeth, Goodwin Peter, Higdon Carla, Rossi Ann Marie, Emerson Erling, Finkelstein Martin, Floyd Eugenia, Harriman Shawn, Atherton Jim, Hillerman Steve, Soderstrom Cathy, Kou Kou, Gant Tom, Noe Mark C, Foster Barb, Rastinejad Farzan, Marx Matthew A, Schaeffer Tracey, Whalen Pamela M and Roberts W Gregory. 20040116. Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy. : Cancer research.

Harvard

Beebe J. S., Jani J. P., Knauth E., Goodwin P., Higdon C., Rossi A. M., Emerson E., Finkelstein M., Floyd E., Harriman S., Atherton J., Hillerman S., Soderstrom C., Kou K., Gant T., Noe M. C., Foster B., Rastinejad F., Marx M. A., Schaeffer T., Whalen P. M. and Roberts W. G. (20040116). Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy. : Cancer research.

MLA

Beebe Jean S, Jani Jitesh P, Knauth Elisabeth, Goodwin Peter, Higdon Carla, Rossi Ann Marie, Emerson Erling, Finkelstein Martin, Floyd Eugenia, Harriman Shawn, Atherton Jim, Hillerman Steve, Soderstrom Cathy, Kou Kou, Gant Tom, Noe Mark C, Foster Barb, Rastinejad Farzan, Marx Matthew A, Schaeffer Tracey, Whalen Pamela M and Roberts W Gregory. Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy. : Cancer research. 20040116.